610 related articles for article (PubMed ID: 27984115)
1. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C
Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.
Bi C; Chung TH; Huang G; Zhou J; Yan J; Ahmann GJ; Fonseca R; Chng WJ
Oncotarget; 2015 Sep; 6(28):26508-18. PubMed ID: 26164366
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M
Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219
[TBL] [Abstract][Full Text] [Related]
5. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
[TBL] [Abstract][Full Text] [Related]
6. Altered miRNA expression in high-fat diet-induced prostate cancer progression.
Nara T; Narita S; Mingguo H; Yoshioka T; Koizumi A; Numakura K; Tsuruta H; Maeno A; Saito M; Inoue T; Tsuchiya N; Satoh S; Habuchi T
Carcinogenesis; 2016 Dec; 37(12):1129-1137. PubMed ID: 27915273
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion.
Li Y; Kong D; Ahmad A; Bao B; Dyson G; Sarkar FH
Epigenetics; 2012 Aug; 7(8):940-9. PubMed ID: 22805767
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C
J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630
[TBL] [Abstract][Full Text] [Related]
10. miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells.
Fujita Y; Kojima T; Kawakami K; Mizutani K; Kato T; Deguchi T; Ito M
Prostate; 2015 Oct; 75(14):1568-78. PubMed ID: 26074357
[TBL] [Abstract][Full Text] [Related]
11. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.
Majid S; Dar AA; Saini S; Shahryari V; Arora S; Zaman MS; Chang I; Yamamura S; Tanaka Y; Chiyomaru T; Deng G; Dahiya R
Clin Cancer Res; 2013 Jan; 19(1):73-84. PubMed ID: 23147995
[TBL] [Abstract][Full Text] [Related]
12. Demethylation of miR-10b plays a suppressive role in ccRCC cells.
He C; Zhao X; Jiang H; Zhong Z; Xu R
Int J Clin Exp Pathol; 2015; 8(9):10595-604. PubMed ID: 26617769
[TBL] [Abstract][Full Text] [Related]
13. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
Goto Y; Nishikawa R; Kojima S; Chiyomaru T; Enokida H; Inoguchi S; Kinoshita T; Fuse M; Sakamoto S; Nakagawa M; Naya Y; Ichikawa T; Seki N
FEBS Lett; 2014 May; 588(10):1973-82. PubMed ID: 24768995
[TBL] [Abstract][Full Text] [Related]
14. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.
Hulf T; Sibbritt T; Wiklund ED; Patterson K; Song JZ; Stirzaker C; Qu W; Nair S; Horvath LG; Armstrong NJ; Kench JG; Sutherland RL; Clark SJ
Oncogene; 2013 Jun; 32(23):2891-9. PubMed ID: 22869146
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
Daniunaite K; Dubikaityte M; Gibas P; Bakavicius A; Rimantas Lazutka J; Ulys A; Jankevicius F; Jarmalaite S
Hum Mol Genet; 2017 Jul; 26(13):2451-2461. PubMed ID: 28398479
[TBL] [Abstract][Full Text] [Related]
17. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.
Jiang H; Yu WW; Wang LL; Peng Y
Oncol Rep; 2015 Sep; 34(3):1153-61. PubMed ID: 26134263
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
19. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.
Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H
J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]